• Product
• KPA, “to discuss ingredient prescribing in upcoming FAPA"
• by Kim JiEun Mar 5, 2024 05:49am

• Product
• NA Opp party in unison say ‘it's time for INN prescribing'
• by Kim JiEun Feb 29, 2024 06:03am

• Product
• Forxiga return policy in question amid AZ-Daewoong dispute
• by Kang, Hye-Kyung Feb 5, 2024 05:54am

• Product
• Shortage no more for Saxenda?...'will increase supply'
• by Kang, Hye-Kyung Jan 15, 2024 05:36am

• Product
• Saxenda’s shortage prolonged…raises inconveniences
• by Kang, Hye-Kyung Jan 10, 2024 05:42am

• Product
• KPDS demands gov. action to end chemotherapy drug shortages
• by Kang, Hye-Kyung Jan 3, 2024 05:40am

• Product
• ‘Cutting budget for essential drugs neglects public health'
• by Kang, Hye-Kyung Nov 10, 2023 05:19am

• Product
• Investigation into companies refusing to supply animal med.
• by Kim JiEun Oct 6, 2023 05:36am

• Product
• Will Insulin being sold out persist for a long time?
• by Kim JiEun Sep 22, 2023 05:41am

• Product
• Phentermine and Saxenda has most reported adverse events
• by Lee, Jeong-Hwan Sep 8, 2023 05:33am